Agoracom Blog Home

Author Archive

Top 5 #Esports industry trends that you should know heading into 2021 – SPONSOR: TGS Esports $TGS.ca $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

Posted by AGORACOM-JC at 3:24 PM on Monday, November 30th, 2020

SPONSOR: TGS Esports Inc. (TGS: TSX-V) is creating the ultimate esports experience, made up of industry professionals with 20+ combined years in the space of tournament organization, league facilitation, and production. This experience combined with the acquisition of Pepper Esports Inc . allows TGS to offer a full suite of tools needed for any player or tournament organizer in esports. Learn More.

TGS Esports Announces Intent to Acquire Canadian Esports and Digital Media  Startup, Volcanic Media

Top 5 Esports industry trends that you should know heading into 2021

The Esports industry is on the boom for the last few years and here the top 5 esports industry trends you should know in 2021

By: Arpan Neema

The Esports industry trends are on the blast for a significant long time now. Numerous speculators have just researched this million-dollar industry. On the off chance that you are additionally wanting to make enormous speculation, at that point esports can without a doubt bring you to benefit.

The esports business was esteemed at $906 million out of 2019 wherein it is relied upon to turn into a billion-dollar industry by 2020. At no other time, esports has been in feature than in this pandemic. Esports is huge, it has got all that you can consider; from esports betting, marketing, publicizing, advanced substance, and much more. Electronic Sports or esports has hit the spot looking to the consideration it got from the individuals around the world. The two novices and experts are helping in forming the new business patterns identified with esports.

Esports has just made its put in the standard and is good to go to become enormous. It has become an alluring specialty for speculators now. Numerous large brands have just become a piece of this. Also, understanding the current esports patterns is significant for every individual who is related to the esports business, straightforwardly, or by implication. Having earlier information about the market patterns of esports is similarly as significant as realizing the informational collections of the space.

Regardless of whether you are a game advancement organization or a non-endemic brand who is further hoping to contribute his/her well-deserved cash. Watching out for the change of the worldwide esports market can assist you with getting bits of knowledge about esports industry measurements and permits you to comprehend your esports crowd better.

In this article you will perceive how esports can enable your business to ascend the stepping stools of progress, here are the main 5 patterns in the esports market for 2020 that you should know to increase the value of your business.

Brand Investments

This is the start! As esports keep on developing, shrewd players will keep up with them as a brand in this way giving more substance to their buyers. Shirts, shoes, and gear, all must now be covered under the enormous brand names.

Conventional games don’t have the degree for brand publicizing yet esports, it is covering everything. The esports crowd is all insane consequently allowing the brands a chance to drive deals and assemble client reliability. PepsiCo’s Brisk was among the principal financial specialists who supported the Rocket League Championship Series. Before long, famous brands like Mastercard, Intel, Mercedes Benz, Puma, Nike, Adidas, Coca-Cola, and numerous others joined the race.

Brands are discovering esports as an occasion to pull in another crowd. What’s more, sponsorships can be an ideal method to accomplish that. Since individuals will in a general change to various brands so effectively and rapidly because of dependability and verification, esports is giving these brands an occasion to make brand mindfulness among the individuals from various geologies.

Anyway, what are the brands that have as of late put resources into esports?

Jaguar has as of late marked a multi-year sponsorship manage Gen.G Sports, a South Korean esports association.

Louis Vuitton, a French extravagance house has additionally declared its cooperation with Riot Games. LV will plan virtual things for games like League of Legends which the players will purchase with genuine cash.

BMW has likewise made a stupendous move in its advertising financial plan for esports.

Taking a gander at the information over, it’s almost certain that the brands are putting resources into esports as they are more likely than not examined the outcomes.

Virtual Reality

The virtual universe of esports is more alluring than the one in reality. It carries more inventive occasions to the individuals who need to make occupations. Furthermore, to guarantee a superior gaming experience, individuals are discovering approaches to use innovation in esports. Prior to the items can be moved with the snap of a catch, computer-generated reality has made it conceivable to encounter it truly. This is the intensity of augmented reality that has made esports players move as well as has given them new space to investigate esports.

This physical to PC communication has permitted players to stand up from their situate and appreciate the game alongside really encountering the field of the game. How energizing it is that even while sitting in your own room you can really go in the game, giving you an extreme spectating experience.

Analysts have additionally discovered that augmented simulation can bring back the genuine endurance, quality, and perseverance in the players that were seen during actual games, for example, baseball and boxing. Consequently, helps in improving their psychological and actual wellbeing too. Carrying these customary wearing exercises to the extent of augmented reality will change the manner in which individuals take a gander at esports.

With this, esports fans are searching for ways, for example, AR or VR that can furnish them with an exciting client experience. Not simply the client experience, VR can drive the promoting in esports easily consequently offering occasions to the advertisers.

Esports Gambling V/s Sports Gambling

Esports is simply not going to be bound to the rivalries, it is significantly more past that. Where individuals are investigating and exploring different avenues regarding different parts of esports, betting remaining parts consistent.

Obviously, the games wagering industry is flourishing hard to stay in the line yet taking a gander at the current situation, esports betting will before long remove the games betting world. Today, individuals can almost wager on everything from governmental issues to film stars and so forth. Esports that has just got a huge crowd and can’t get away from the betting game.

With the effect of COVID-19 on the games betting industry, analysts and specialists have seen an abrupt decrease in sports betting exercises and the end of conventional gambling clubs. In spite of the fact that there are games and occasions that actually hold bookmakers and punters, there has been an abrupt expansion in Esports betting.

Numerous game wagering programming advancement organizations have shafted to make esports wagering programming and items to stay serious on the lookout. New companies and business firms are searching for stages that are solid and comprehend the requirement for esports purchasers.

In spite of the fact that esports wagering items are far less evolved when contrasted with the conventional games wagering, bookmakers are investigating the universe of esports and contrasting it with the unpredictability with that of the esports. As indicated by Narus Advisors and Eilers and Krejcik Gaming, the most popular esports titles can be somewhat confounding to the esports speculators to comprehend. Then again, “the large three”, CS: GO, League of Legends, and Dota 2 all in all reports 85% of the esports wagering pattern. Different esports that are popular in esports betting incorporate starcraft-2, Call of Duty, and numerous others.

Wagering on esports is completely another idea for the amateurs. The change of wagering through an advanced reality where no actual fascination will happen would have its own repercussions. Yet, glancing forward in the coming years, more online esports wagering networks will be made and esports betting may take the state of sports betting outperforming it. 

Expansion of the network

The development of esports will likewise bring about the extension of the organization. Expanding viewership will be one of the main elements to drive income development. It includes both infrequent watchers and customary watchers.

In 2018, there were 200 million successive watchers and 165 esports fans who dedicatedly viewed their most loved esports. As indicated by Statista, by 2023, there are 300 million continuous watchers who are required to watch esports around the world.

Newzoo has additionally given information around the esports viewership that predicts the yearly development rate will go up by 14% before the finish of 2021. Also, they anticipated that there will be 307 million periodic watchers while 250 million esports fans adding the absolute to 557 million watchers before the finish of the very year.

Along these lines, information from the greatest two information firms from the specialty has just given a thought regarding the colossal development in viewership of esports around the world. Also, there is no uncertainty that taking a gander at the current circumstance, it is, at any rate, going to take a delay.

Esports viewership is legitimately identified with the attention to it. An ever-increasing number of individuals are finding out about esports. The excursion from two or three thousand to a couple million was not harsh as esports spread broadly like fire in the woods.

The numbers proceed to develop and by 2019 roughly 1.5 billion individuals were at that point familiar with esports. Also, this was conceivable due to the live streaming stages that performed esports industry examination at the extremely beginning stage and had begun to communicate live occasions and matches of esports.

Prior there were relatively few offices to the esports networks to stream their most loved esports because of information speed and different conditions. Be that as it may, with the headway in innovation, it made it workable for them to welcome individuals from various topographies to appreciate viewing their most loved esports.

As indicated by Streamlabs, Twitch and Youtube together have over 1.13 million dynamic clients. In this way, these numbers are sufficient to state that esports has just crossed enormous numbers in making client drawing in content with loads of exercises on the streaming stages and the numbers will develop to an ever-increasing extent.

Jerk has as of late dispatched a devoted catalog for esports lovers.

These bits of knowledge will clearly help organizations and new companies to think the correct way of taking a gander at the current esports market development and pattern in the esports business. A portion of these patterns are certainly going to show and some may set aside more effort to create overall. Be that as it may, generally, every one of them will assume a part in raising esports to another level. Promoters who are as yet arranging can make the most of this chance, as there are countless brands who have just made up their psyches to support distinctive esports occasions.

In the wake of breaking down the esports markets and patterns, it is certain that esports is unquestionably not halting in the coming years. Financial specialists can receive a lot of rewards in the quickly developing scene of esports. Along these lines, this is truly going to be the time of a lot of chances for the ones who are intending to put resources into esports.

Everyone will be entertained

Esports has the ability to take close by the rising excitement of the crowd. Esports isn’t just about the experts who win a great many dollars in opposition however even to the beginners who are taking a make a plunge in this brilliant universe of esports. As is the solid energy the esports watchers who take ordinary subsequent meet-ups on matches and occasions in this manner adding to the viewership.

From beginners to experts, card sharks, watchers, esports will engage all the lives. The developing portable network of esports players has additionally crossed the records. Portable esports have likewise become principally a significant piece of esports.

An investigation shows that around 70-80 % viewership of esports is coming from men, and there is still an extension for the ladies to enter the ever-developing industry. The esports network will develop this year at a quick rate. The developing number of online esports devotees and players worldwide will surpass the previous numbers in the coming years. With in-game live talk alternatives, brand influencers, gatherings, and numerous different choices will lead gamers to join an ever-increasing number of conversations prompting a bigger gathering of network individuals.

Different online media stages and discussions, for example, Reddit are making client drawing in substance to interface players from over the world. These people group will prepare for new gaming encounters making esports more intelligent and engaging the esports players and lovers.

As per Echarts, Arena of Valor is the most popular esports game on versatile played worldwide in the year 2019 followed by PUBG Mobile. The headway in versatile innovation will prompt more number of esports lovers. Newzoo reports that Mobile esports produced 50 million live viewership hours from Sept to Nov 2019—around multiple times more than a similar period in 2018.

Source: https://apptrigger.com/2020/11/30/esports-industry-trends-2021/

AGORACOM Small Cap 60: Innocan $INNO.ca #CBD Products Ready For Launch With Positive Clinical Test Results $CGC.ca TLRY $VFF.ca $APHA $OVAT.ca $KHRN.ca

Posted by AGORACOM-JC at 2:33 PM on Monday, November 30th, 2020
Innocan-Blog

Innocan (INNO:CSE) has 3 fully operating divisions to address the market for Cannabis products.  As a Cannabis investor, why limit yourself to a Company with just one specialty, when Innocan offers you exposure to both the exploding world of cannabis pharma, as well as, a portfolio of patent-pending and launch ready consumer health products.

TGS Esports $TGS.ca Forms Discover Management To Support the Next Wave of Gaming Creators, Influencers, and Streamers $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

Posted by AGORACOM-JC at 9:15 AM on Monday, November 30th, 2020
TGS Esports Announces Intent to Acquire Canadian Esports and Digital Media  Startup, Volcanic Media
  • Teamed up with Riley Trimble , formerly of Spire Management, and Marius Adomnica, of Segev LLP, to form Discover Management, a full service management company to help esports influencers, content creators and players realize their full value
  • “At TGS we are working with creators on a daily basis. One constant we have dealt with is that creators love creating but may not have the experience with brand deals or legal matters” said Spiro Khouri , co-founder and CEO of TGS. “We’re helping creators legitimize their career path and guiding them through that process. At the same time, we’re able to connect our partner brands with creators to create mutually beneficial relationships.”

VANCOUVER, BC , Nov. 30, 2020 – TGS Esports Inc. ( “TGS” or the ” Company” ) (TSXV: TGS) (FRA:5RH) has teamed up with Riley Trimble , formerly of Spire Management, and Marius Adomnica, of Segev LLP, to form Discover Management, a full service management company to help esports influencers, content creators and players realize their full value.

“At TGS we are working with creators on a daily basis. One constant we have dealt with is that creators love creating but may not have the experience with brand deals or legal matters” said Spiro Khouri , co-founder and CEO of TGS. “We’re helping creators legitimize their career path and guiding them through that process. At the same time, we’re able to connect our partner brands with creators to create mutually beneficial relationships.”

Twitch, the leading platform for gaming content creators, had over 1.77 Billion hours watched in October 2020 with a daily average of just under 2.5 million unique viewers 1 . Content creators and other esports influencers are a vital component of the gaming ecosystem. New titles such as Fall Guys and Among Us rose to popularity with help of the recommendation of influencers and streamers. Existing games also lean heavily on creators to build and sustain interest in the property. In addition, creators serve as a vital lifeline between the brands they work with and their audiences. These factors have combined to make relationships with influencers an invaluable component of the marketing for any brand seeking to reach gamers.

“We understand the value that content creators bring to the table,” said Justin Simpao , General Manager of Discover Management. “At the same time, we can help influencers deal with niche situations that arise from the growing ecosystem of influencer business. This includes curating partnerships, innovating ways to help our creators grow their personal brand, and handling the complex administrative details such as self-incorporation and finance management.”

Riley Trimble was previously a partner and COO in Spire Management, a content creator management organization. SpireMGMT’s signed creators had over 148,000,000 watch time minutes per month with over $152,000 USD per month in Twitch revenue. He also cultivated partnerships with brands including G Fuel, Nord VPN, and MainGear PC.

Marius Adomnica is an esports lawyer who has been on the forefront of supporting the development of the esports industry in Western Canada . Marius has over a decade of legal experience and has worked extensively with content creators as well as esports teams, tournament organizers and players. He also serves as an advisor and on the board of directors for various companies and non-profit organizations in the industry. Marius looks forward to using his legal experience to assist Discover’s clients.

“Discover Management has a desire to help grow the content creator space,” Simpao continued. “Having been both fans and a part of the creative community for many years has given us a unique understanding of the space. This endemic understanding of the industry is one of many things our team at Discover brings to the table.”

About TGS Esports Inc.
TGS Esports Inc. is an organization focused on creating the ultimate esports experience. TGS is made up of industry professionals with 20+ combined years in the space of tournament organization, league facilitation, and production. This experience combined with the acquisition of Pepper Esports Inc . allows TGS to offer a full suite of tools needed for any player or tournament organizer in esports. TGS is also the owner of Canada’s first dedicated esports arena, The Gaming Stadium, located in Richmond, British Columbia , which opened in June 2019.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

On behalf of the Board of Directors

Spiro Khouri
Spiro Khouri , CEO
TGS Esports Inc.

Disclaimer for Forward-Looking Information
Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future, including with respect to: the hosting of an NBA2K tournament for high school students in the Chicago area; the timing, format and prizes for the tournament; and the intended use of the proceeds from the tournament. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including risks related to factors beyond the control of the Company. The risks include the following: the unknown magnitude and duration of the effects of the COVID-19 pandemic and other risks that are customary to transactions of this nature. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them.

This press release is not an offer of the securities for sale in the United States . The securities have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an exemption from registration.  This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful

MedX Health Corp. $MDX.ca Announces Third Quarter 2020 Financial Results and Grant of Stock Options $DMTK $LMD.ca $DOC.ca $DOCRF $WELL.ca $PRN.ca

Posted by AGORACOM-JC at 8:20 AM on Monday, November 30th, 2020
Home - MedX Health
  • Company reported revenue of $172,889 for the three months ended September 30, 2020, compared with revenue of $234,977 for the three months ended September 30, 2019.
  • Revenue from SIAscopy ® of $74,286 for the third quarter was 29% higher than the prior year three-month period and more than twice that of the three months ending June 30, 2020.
  • Revenue from the Company’s therapeutic laser line of $98,603 was a decrease from $177,436 in the prior year period, but $60,180 higher than in the prior three month period.

MedX Health Corp. (“MedX” or “Company”) (TSX-V: MDX) announced its results for the three and nine-months ended September 30, 2020, which are also available on SEDAR ( www.sedar.com ).

The Company reported revenue of $172,889 for the three months ended September 30, 2020, compared with revenue of $234,977 for the three months ended September 30, 2019. Revenue from SIAscopy ® of $74,286 for the third quarter was 29% higher than the prior year three-month period and more than twice that of the three months ending June 30, 2020. Revenue from the Company’s therapeutic laser line of $98,603 was a decrease from $177,436 in the prior year period, but $60,180 higher than in the prior three month period. The Company reported a loss for the three months ended September 30, 2020 of $1,083,772 or $0.01 per share compared with a loss of $577,648, or $0.00 per share for the three months ended September 30, 2019.

The Company reported revenue of $337,885 for the nine months ended September 30, 2020, compared with revenue of $678,886 for the nine months ended September 30, 2019. Revenue from SIAscopy ® of $127,093 was 21% higher than in the first nine months of 2019. Revenue from the Company’s therapeutic laser line of $210,792 for the nine-month period was 63% lower than the $574,069 in the prior year period. The Company reported a loss for the nine months ended September 30, 2020 of $2,532,171 or $0.02 per share, compared with a loss of $2,086,892, or $0.01 per share for the nine months ended September 30, 2019.

“We are pleased that we had strong revenue growth in Q3 compared to Q2, as we more than doubled revenue in each of our product lines,” noted Rob von der Porten, Executive Chairman, and acting CEO. “We made our first shipment of SIAscopy ® units to our Brazilian distribution partner, where they will be deployed on our DermSecure ® platform over the coming months. The sales and marketing team are building a pipeline of international distribution partners for our SIAscopy ® on DermSecure ® telemedicine platform and are experiencing strong interest in the Company’s unique teledermatology platform. While COVID-19 will continue to have an impact on all businesses, it is increasing the interest in telemedicine in general, albeit it is impacting the rate of implementation. While our revenue increased over the second quarter, the loss for the quarter was higher as we built out our sales team, increased marketing efforts, and spent on continued enhancements to our DermSecure ® platform, and as well, we incurred non-cash share-based compensation expense. We remain convinced that we will have long-term, sustainable growth with the MedX DermSecure ® platform and that it is the ‘Gold Standard’ in the teledermatological market space.”

The Company also announces that 800,000 stock options have been granted to Directors. Such options have an exercise price of $0.17 per share, will expire on November 25, 2025, and vest immediately.

MedX also announces it has retained Venture North Capital Inc. (“Venture North”) for strategic marketing, investor relations and capital markets communications services. Venture North will arrange and attend meetings with professional investors, maintain ongoing contact and broaden relationships with the professional investment community on MedX’s behalf.

Under the terms of the agreement, MedX will pay Venture North a monthly fee of $6,000 for ongoing strategic services for an initial six (6) months, after which the relationship will continue on a monthly basis. The agreement may be terminated by MedX or Venture North on 60 days written notice. Venture North will also be granted stock options (the “Options”), totaling up to 900,000 common shares of the Company, which will vest and become exercisable quarterly with 225,000 of the options vesting on each of the dates that are three, six, nine and twelve months from the beginning of the Engagement Period. The Options will be exercisable at a price of $0.17 per share for a period of two years. The appointment and option grant are subject to TSX Venture Exchange approval.

Summary of Recent Announcements:

The following is a summary of recent announcements made by the Company, for which further details can be found under the Company’s profile at www.sedar.com .

MedX Announces Sales Agency Agreement with Ziemer Professional Corp.

On October 28, 2020, the Company announced it had completed a sales agency agreement with the Ziemer Professional Corporation. Ziemer will target its sales efforts within the medical, athletic, and pain management clinic markets. Six new clinics will begin installing the SIAscopy ® on Dermsecure ® telemedicine platform across Ontario and Saskatchewan.

MedX Adds Two New Members to Board of Directors

On October 15, 2020, the Company appointed Anthony Milonas and Wayne Cockburn as Directors of the Company. Mr. Milonas and Mr. Cockburn bring extensive senior management experience working with medical device and health care growth-stage companies, both nationally and internationally. Mr. Milonas is President and CEO of Canadian Orthodontic Partners, a company overseeing a national network of orthodontic practices. Mr. Cockburn is President of The Clinic Network Canada, one of Canada’s largest providers of out-of-hospital pain management services.

MedX Expands Senior Leadership Team

On September 21, 2020, the Company announced the appointment of veteran healthcare industry executive Naman Demaghlatrous as Managing Director, Europe, Middle East & Africa (“EMEA”), and Chantal Ward, RN, as Director, Dermatological Services. Mr. Demaghlatrous brings more than 20 years of experience in the healthcare industry, including roles with companies such as Medtronic, Pediapharm, Johnson & Johnson and Atfal Pharma. Chantal Ward, RN, a Diploma Nurse Graduate with an operating room background, has 20+ years’ experience as a clinical trainer of advanced medical aesthetic equipment and technology.

MedX Announces Management Changes and Increased Focus on SIAscopy® on DermSecure®

On September 9, 2020, the Company announced management changes to enhance its focus on its dermatological services and products including DermSecure ® and SIAscopy ® . Mike Druhan, who has championed SIAscopy ® within the Company for a number of years, has been appointed President, Dermatological Services and Products. Louie Canitano, who has many years of experience in therapeutic laser and light products has been appointed Managing Director, Light Therapy Products.

MedX Announces Closing of Non-Brokered Private Placement

On August 4, 2020, the Company announced that further to the Conditional Approval from the TSX Venture Exchange for a non-brokered Private Placement to accredited investors of up to 16,666,666 units at $0.12 per unit (“Unit”), to raise up to $2,000,000, the closing of a first tranche of that placement has taken place on July 31, 2020, for a total of 2,600,000 units, raising a total of $312,000. Each Unit is comprised of One (1) fully paid common share and One (1) Share Purchase Warrant, exercisable to purchase One (1) further Common Share at the price of $0.20, exercisable for a period of two years from the date of issue. The securities issued will be restricted from trading for four months from the date of issue. In connection with this tranche of the private placement, cash commissions of $24,000 were paid.

About MedX

MedX, headquartered in Mississauga, Ontario, is a leading medical device and software company focused on skin health with its SIAscopy ® on DermSecure ® telemedicine platform, utilizing its SIAscopy ® technology. SIAscopy ® is also imbedded in its products SIAMETRICS™, SIMSYS™, and MoleMate™, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are Health Canada, FDA, TGA and CE cleared for use in Canada, the US, Australia, New Zealand, the European Union, Brazil and Turkey. MedX also designs, manufactures and distributes quality photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. www.medxhealth.com .

This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of applicable Canadian securities legislation. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company’s limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company’s projections or forward-looking statements. All forward looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201130005362/en/

MedX Health Corp
Rob von der Porten
[email protected]

Investor Relations
Bill Mitoulas
[email protected]
Tel: +1.416.479.9547

Kontrol Energy $KNR $KNR.ca $KNR.c $KNRLF Files Patent Applications With the U.S. Patent and Trademark Office and the Canadian Intellectual Property Office for Its #Biocloud Technology $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 8:15 AM on Monday, November 30th, 2020
kontrol-logo
  • Announced that as a follow up to its press release dated September 23rd, 2020, the Company has filed four patent applications for its BioCloudTM Technology.
  • Four patent applications have been filed, three with the U.S. Patent and Trademark Office and one with the Canadian Intellectual Property Office : SYSTEM AND METHOD FOR DETECTING AIRBORNE PATHOGENS

TORONTO, ON / November 30, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company”) a leader in smart buildings and smart cities through IoT, Cloud and SaaS technology is pleased to announce that as a follow up to its press release dated September 23rd, 2020, the Company has filed four patent applications for its BioCloudTM Technology.

Four patent applications have been filed, three with the U.S. Patent and Trademark Office and one with the Canadian Intellectual Property Office : SYSTEM AND METHOD FOR DETECTING AIRBORNE PATHOGENS.

“These patent applications address key attributes of our technology, which utilizes a combination of continuous air quality monitoring and a proprietary detection chamber to target and identify airborne pathogens to help create safer spaces,” says Paul Ghezzi, CEO Kontrol. “We are very proud of our team and the milestone this represents. Innovation is at the core of our operations and we continue to execute on our plans.”

About Kontrol BioCloud

BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others.

BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).

About Kontrol Energy

Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in smart buildings and smart cities through IoT, Cloud and SaaS technology. Kontrol Energy provides a combination of software, hardware and service solutions to its customers to improve energy management, air quality and deliver continuous emission monitoring.

Additional information about Kontrol Energy Corp. and BioCloud can be found on its websites at www.kontrolenergy.com and www.kontrolbiocloud.com, and by reviewing its profile on SEDAR at www.sedar.com


For further information, contact:

Paul Ghezzi, Chief Executive Officer
[email protected] or [email protected]
Kontrol Energy Corp.
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer (BioCloud) are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

SOURCE: Kontrol Energy Corp.

Empower Clinics $CBDT.ca $EPWCF Signs North American Distribution Agreement with API Pharma USA For FDA EUA #COVID-Rapid Antigen & Antibody Tests. Supported Three Months of Clinical Trials $WELL.ca $DOC.ca $DOCRF $VMD.ca $VPT.ca $ADK.ca

Posted by AGORACOM-JC at 7:21 AM on Monday, November 30th, 2020
  • Announce the North American Re-Seller & Distribution Agreement with API Pharma (“API”) for its FDA EUA submitted Rapid Antigen Test and Rapid Antibody Test.
  • Empower’s KAI Medical Laboratory provided API significant scientific data through three months of clinical trials.
  • As a result, Empower and API are now able to sell these products with confidence, on an unlimited basis, to its customers and prospective customers nationwide in the United States and in European countries supporting CE mark approval.

VANCOUVER, BC / November 30, 2020 / EMPOWER CLINICS INC. (CBDT:CSE) (8EC:Frankfurt) (EPWCF:OTCQB) (“Empower” or the “Company“) an integrated healthcare company serving a database of 165,000 patients through clinics in the Southwest United States, a telemedicine platform and medical diagnostics laboratory is pleased to announce the North American Re-Seller & Distribution Agreement with API Pharma (“API”) for its FDA EUA submitted Rapid Antigen Test and Rapid Antibody Test.

Empower’s KAI Medical Laboratory (“KAI”) provided API significant scientific data through three months of clinical trials. As a result, Empower and API are now able to sell these products with confidence, on an unlimited basis, to its customers and prospective customers nationwide in the United States and in European countries supporting CE mark approval.

Furthermore, Empower and KAI are providing API with support for its Health Canada submission for its Rapid Antigen Detection Test (“RADT”) (COVID-19 Application For Authorization If Import Or Sale Of Medical Devices). Empower will have Canadian distribution rights upon Health Canada approval.

Steven McAuley, Chairman and CEO of Empower stated “Our society is experiencing unprecedented changes that are affecting how we go back to work, how we travel and how we might gain permission to interact with others. Testing protocols and testing products are becoming a part of our daily lives, and there are key differences between PCR, antigen and antibody tests. They are all important, irrespective of how potential vaccines come to market. Our company is leading and positioned to provide all of these important tests to the markets we serve.”

The global COVID-19 diagnostics market size is valued at USD 19.8 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 3.1% from 2021 to 2027. These tests are critical in the management of the ongoing COVID-19 pandemic for accurate diagnosis as well as for tackling the spread of the infection (https://www.grandviewresearch.com/industry-analysis/covid-19-diagnostics-market)

WHAT IS A RAPID ANTIGEN DETECTION TEST (RADT)?

An RADT is a rapid diagnostic test suitable for point-of-care testing that directly detects the presence or absence of an antigen. This distinguishes it from other medical tests that detect antibodies or nucleic acid, of either laboratory or point of care types.

WHAT IS AN ANTIBODY TEST?

An antibody test, also known as a serology test, looks for specific antibodies in your blood. This test is useful because it shows if someone has had the infection in the past, even if you had only mild symptoms.

One inherent advantage of an antigen test over an antibody test is that it can take time for the immune system to develop antibodies after infection begins, but the foreign antigen is present within a preliminary incubation period of five days or less.

GOVERNMENT OF CANADA – RADT’s WILL HAVE AN IMPORTANT ROLE TO PLAY

The Government of Canada website for the use of RADT stated the following”

“Potential characteristics of these tests (faster turnaround time, lower per-test cost, ability to do the test in a setting by non-professionals on a more frequent basis, amongst others) suggest that they will have an important role to play in the next phase of the response. It is important for the public health, infectious diseases experts and laboratory communities to identify the scenarios where the use of RADTs may further strengthen the public health response by expanding access to testing”

(https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/guidance-documents/use-rapid-antigen-detection-tests.html)

API PHARMA – NO CHOICE BUT TO RAPID TEST

Rapid testing is critical to any strategy for containing COVID-19. It helps determine where the virus is spreading, who has immunity and how widely the virus has spread.

The COVID-Rapid Antigen Test determines who has the virus at present and is likely to be contagious. With >99% sensitivity for those who are contagious, the rapid results allow healthcare providers to make quick and accurate medical decisions.

The COVID-Rapid Antibody Test, which screens blood for antibodies, can allow hospitals and workplaces to identify people who were infected and may have already developed immunity. Studies have shown that one-third to one-half of those infected with COVID-19 are asymptomatic. As a result, serology tests help determine who can lead the way back to reopen businesses and work on the front lines of health care.

The COVID-Rapid line of tests are accurate and affordable so it can be used for testing large populations. America has no choice but to rapid test for COVID-19 so that governments, schools, and workplaces can test large groups of individuals, not just those who present with symptoms.

API PHARMA RADT DEMONSTRATED HIGHLY EFFECTIVE ON 3 CONTINENTS

API Pharma’s COVID-Rapid Antigen test has been tested and demonstrated to be highly effective on three continents. This is important as it demonstrates all the different strains of the virus will respond equally to the rapid antigen test. Clinical studies were carried out specifically in China, the United States and Poland.

PARTNERSHIP FURTHER SOLIDIFIES KAI MEDICAL FOOTHOLD IN COVID-19 TESTING SPACE

The clinical trials of API products performed a variety of studies including the precision, accuracy, sensitivity, and interfering substances, as well as, the efficacy of operators to perform the test accurately. These studies ensure that API-products meet industry standards for testing and will accurately identify COVID-19 positives as well as COVID-19 negatives.

Because of API’s focus on Rapid, Point-of-Care testing for both antibodies and antigens, in addition to Kai Medical’s extraordinary capacity to handle industry-standard turnaround times for RT-PCR testing, this partnership further solidifies Kai Medical’s foothold in the COVID-19 testing space.

Yoshi Tyler, President of KAI Medical Laboratory stated “We anticipate that, moving forward, there will be a focus on much more rapid and accurate point-of-care testing, in order to return to everyday life. Like the virus, our testing strategies must be adaptable. As we move forward, we continue to prioritize the best and most efficacious testing strategies.”

KAI Medical Laboratory operates a high-complexity CLIA and COLA accredited laboratory that provides reliable and accurate testing solutions to hospitals, medical clinics, pharmacies, and employer groups. KAI has taken an active role in COVID-19 testing, battling the pandemic through RT-PCR testing and serology testing with the capacity to process 4,000 RT-PCR test specimens per day. While the RT-PCR test identifies if a patient has an active virus, the serology or antibody test detects if a patient has previously been exposed to the virus. Both of these test results are vital to managing outbreaks and the potential spread of coronavirus.

As a result of this capability, Empower is now able to expand phase four of its COVID-19 testing rollout which was first announced on April 27, 2020 beginning with testing in-clinic testing (Phase 1) and culminating with a nationwide roll-out across the United States (Phase 4). Phase 4 allows Empower to service enterprise level clients, including movie and television studios that require reliable, accurate, fast and mass batch testing capabilities in order to resume production in a safe and compliant manner.

ABOUT API PHARMA

API Pharma (API) is an industry leader in designing and distributing rapid tests for a range of viruses and diseases, including rotovirus, influenza, hepatitis, herpes, HIV, and others.

API’s rapid COVID-19 test is nearly as simple as a home pregnancy test, requiring only a few drops of blood from a finger stick and a drop of reagent. Results are available in under 20 minutes and are simple to interpret: one line means negative, two lines means positive. The test has 97% sensitivity and 97% specificity, and API’s long experience with rapid tests makes it a reliable provider. API currently has approval to provide test kits to medical facilities in the U.S. and expects to have FDA approval for home use soon. The test is already in use in Europe.

ABOUT EMPOWER

Empower is creating a network of physicians and practitioners who integrate to serve patient needs, in-clinic, through telemedicine, and with decentralized mobile delivery. A simplified, streamlined care model bringing key attributes of the healthcare supply chain together, always focused on patient experience. The Company provides COVID-19 testing services to consumers and businesses as part of a four-phased nationwide testing initiative in the United States. Empower recently acquired Kai Medical Laboratory, LLC as a wholly owned subsidiary with large-scale testing capability.

ABOUT Kai Medical Laboratory

Our mission is to change healthcare through science & innovative quality care by providing value added services, accuracy, and consistency. Our unwavering commitment to quality compliance and scientific innovation elevates Kai Medical Laboratory to a new standard in patient care. Kai Medical Laboratory is located in the Dallas Medical District in close proximity to some of the largest healthcare groups in the U.S. including Parkland Hospital, UT Southwestern, Children’s Medical Center, Baylor Scott & White Health (Dallas), Tenet Healthcare (Dallas), CHRISTUS Healthcare (Dallas).

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Dustin Klein
Director
[email protected]
720-352-1398

Investors: Steven McAuley
CEO
[email protected]
604-789-2146

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include, but are not limited to, statements regarding: the expected benefits to the Company and its shareholders as a result of the acquisition of Kai Medical Laboratory; the transaction terms; the expected number of clinics and patients following the closing; the future potential success of Kai Medical Laboratory, Sun Valley’s franchise model; the anticipated date of closing of the acquisition and the occurrence thereof; and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2020 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the Kai Medical Laboratory acquisition may not be completed on the terms expected or at all; that the Company’s products may not work as expected; that the Company may not be able to expand COVID-19 testing; that legislative changes may have an adverse affect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed transaction; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

VIDEO – Loop Insights $MTRX.ca $RACMF Talks To Shareholders Live From T-Mobile Arena #NCAA #VegasBubble $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 12:56 AM on Saturday, November 28th, 2020
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png

On October 8, 2020 Loop Insights (MTRX:TSXV) (RACMF:OTCQB) announced it had been  “Selected as the Premier Venue Tracing and Fan Engagement Solution for NCAA College Basketball “Bubble” in Las Vegas”.

In that press release, MTRX CEO Rob Anson stated:

“Interest in Loop’s integrated contactless platform by NCAA Division I conferences, schools, and now events have been significant over the past couple of months as they desperately search for best of breed solutions that will allow them to safely restart operations and generate revenue. Being selected for the Vegas bubble is more validation and another major opportunity for Loop to showcase our contactless capabilities on a large-scale project with a global audience. With this agreement, it is fair to say that Loop continues to be the leader in live venue contactless technology.”

Fast forward to today and investors get a chance to see Anson on the floor of T-Mobile Arena answering shareholder questions and providing them with further insight into where the Company is going with its integrated contactless platform …. and he does it all while avoiding getting dunked on by the Washington Huskies Women’s Basketball Team who were practicing at the exact same time 🙂

If you missed the live version, don’t miss this on demand version.

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

AGORACOM Small Cap 60: Innocan $INNO.ca Developing The Pharmaceutical Guided Missile To Defeat #Coronavirus Lung Infections $CGC.ca $APHA $OVAT.ca $KHRN.ca

Posted by AGORACOM-JC at 12:53 PM on Friday, November 27th, 2020
Innocan-Blog

Innocan Pharma Corporation (INNO:CSE) (IP4:FSE) has 3 fully operating divisions to address the market for Cannabis products.  As a Cannabis investor, why limit yourself to a Company with just one specialty, when InnoCan offers you exposure to both the exploding world of cannabis pharma, as well as, a portfolio of patent-pending and launch ready consumer health products.

SustainCo $SMS.ca Announces Name Change and New Ticker Symbol – > Universal PropTech $UPI.ca

Posted by AGORACOM-JC at 11:44 AM on Friday, November 27th, 2020
  • Announced today that, further to its press release dated November 10, 2020, it has changed its name from “SustainCo Inc.” to “Universal PropTech Inc.

Toronto, Ontario–(November 27, 2020) – SustainCo Inc. (TSXV: SMS) (“SustainCo” or the “Company“) announces today that, further to its press release dated November 10, 2020, it has changed its name from “SustainCo Inc.” to “Universal PropTech Inc.

At the opening of the markets on December 1, 2020, the Company’s common shares will commence trading under the new name Universal PropTech Inc. and the new ticker symbol “UPI”. The Company’s new CUSIP number is 91380M100 and its new ISIN is CA91380M1005.

The Company has launched its new logo, brand and website, www.UniversalPropTech.com.

There is no consolidation of the Company’s share capital in connection with the name change. As a result, shareholders are not required to exchange either existing share certificates for new certificates bearing the Company’s name. The name change does not affect the Company’s share structure or the rights of the Company’s shareholders, and no further action is required by existing shareholders.

“Universal PropTech is delivering de-risked proptech investments by using our 40 years HVAC/Building Controls company to integrate proptech into healthy buildings,”  stated Chris Hazelton, Chief Executive of Officer of Universal PropTech Inc. “We are actively seeking new proptech investments to bring to market in Canada.”

The Company also announces today that, further to its press release dated November 23, 2020, it has issued an aggregate of 60,536 common shares at a deemed exercise price of $0.28 per share in connection with the first payment of $15,000 + HST due to Agoracom Internet Relations Corp. pursuant to the advertising agreement with the Company dated November 17, 2020. The common shares are subject to a 4 month plus one day hold period.

About Universal PropTech Inc.

Universal PropTech Inc. (TSXV: UPI), conducts its operations through its wholly-owned subsidiary, VCI Controls Inc. (“VCI“), a leading supplier and integrator of proptech healthy building solutions and services. The Company is an industry leader in the development of intelligent building technology, including the integration of all building systems utilizing the latest in communications technologies and standards. VCI’s business focuses on digital controls and mechanical services, performance monitoring, and energy efficiency solutions.

With headquarters in Toronto, Universal PropTech has offices across Canada including, Halifax, Montreal, and Ottawa. For more information, visit www.universalproptech.com.

Forward-Looking Statements

Certain information provided in this press release constitutes forward-looking statements and information within the meaning of applicable securities laws. Forward-looking information typically contains statements with words such as “anticipate”, “believe”, “forecast”, expect”, “plan”, “intend”, “estimate”, “propose”, “project”, or similar words suggesting future outcomes. The Company cautions readers and prospective investors in the Company’s securities not to place undue reliance on forward-looking information as, by its nature, it is based on current expectations regarding future events that involve a number of assumptions, inherent risks and uncertainties, which could cause actual results to differ materially from those anticipated by the Company.

The forward-looking information included herein is expressly qualified in its entirety by this cautionary statement. The forward-looking information included herein is made as of the date hereof and the Company assumes no obligation to update or revise any forward-looking information to reflect new events or circumstances, except as required by law.

Neither the Exchange, nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

CONTACT INFORMATION

Universal PropTech Inc.
Chris Hazelton
Chief Executive Officer
(647) 300-2957

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/69098

The Top 5 Industries That Will Benefit the Most From Augmented Reality #AR – SPONSOR: Imagine AR $IP.ca $IPNFF $DBO.ca $YDX.ca $SEV.ca $NTAR.ca

Posted by AGORACOM-JC at 11:19 AM on Friday, November 27th, 2020

SPONSOR: Imagine AR Inc. (IP:CSE) (IPNFF:OTCQB) is an Augmented Reality platform that allows businesses to easily launch AR campaigns. Clients Include: NBA Sacramento Kings, Mall of America, AT&T Shape and The Basketball Hall of Fame. ImagineAR and NFL Alumni Academy recently signed a 5 year partnership agreement. The company was selected by Canadian pharmacy chain Shoppers Drug Mart to deliver Immersive AR Conference Experience and if that’s not enough, Imagine AR just signed its second La Liga team to provide AR experiences for fans.  Learn More.

http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

The Top 5 Industries That Will Benefit the Most From Augmented Reality

By Roger Bishop

Augmented reality and virtual reality get most of their fame from the videogame industry, but the more practical uses are becoming more and more utilized across almost every major industry in the United States. Virtual reality is a complete sensical change from an individual’s given surrounding, and generally involves putting on some kind of encompassing headgear that shuts out what is actually around the users. Augmented reality, on the other hand, utilizes technology created to interact with reality, “augmenting” what is actually already there. One of the simplest examples would be a photo filter on your phone that adds sunglasses to whomever you’re taking a picture of. This article will take a look at 5 industries that can (or are already) benefit from evolutions in Augmented Reality (AR).

Construction

Augmented reality in construction can serve a number of purposes, with two of the most important being in safety and saving money. The U.S. construction business generates more than $1.2 trillion every year, and employs more than 7 million Americans. With that many players in the game, even pennies saved here and there can add up quickly. Recent trends, mainly caused by regulation and availability from the public sector, have shown lacks of productivity in the construction industry caused by poor design, poor management, and lacks in development.

AR models can help identify design issues before building starts, saving time and money, and can also help during construction, showing precise directions regarding certain installations and trades. AR is also being heavily utilized in training, and the construction sector is following suit.

Rehabilitation

The uses for AR in healthcare are aplenty, and growing by the day; however, most uses are still in a “clinical trials” phase to determine what is working and what is not. When it comes to rehab, though, AR is already a proven means of increasing therapy outputs. For PTSD, in particular, augmented reality programs can help patients take very small “doses” of whatever causes their trauma in an attempt to slowly ween them off the fear. For soldiers, this can mean subtly adapting to loud noises in a controlled environment until those noises and interruptions no longer act as triggers for past traumatic experiences.

Nursing

For nursing, training is a part of the weekly grind. From cultural diversity training to new procedures, nurses are permanently learning, and AR is giving them a chance to do so in a much more effective manner. Smart glasses are a new technology that allow nurses to work on a patient while having information about the procedure appear, literally, right in front of their eyes on a glass screen that is something out of a James Bond film. This AR training also allows for nurses to get more experience without actually working on a sick individual.

Education

As a whole, the education sector serves to benefit greatly from AR as well. For trade schools, the possibilities are almost endless, but even general, every day education is enacting some forms of augmented reality into their curriculums. There are many AR apps being tailored for education, and as long as schools can provide equal means of utilizing these technologies among all students, the interactive aspects are expected to help students stay focused, as well.

Video Games

Of course, video games are still the industry that most of us first saw AR in action, with the Pokemon Go’s of the world, and the industry certainly isn’t shying away from AR now that it’s becoming popular in other sectors of business. Global augmented reality is the “new future” and allows gamers to, literally, see things that only exist digitally, all across the actual world we live in and breath on every day.

Source: https://www.universenewsnetwork.com/2020/11/27/the-top-5-industries-that-will-benefit-the-most-from-augmented-reality/